Cullinan Associates’s ASML ASML Stock Holding History

Cullinan Associates’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.43M	Hold	2,600	–	–	0.28%	72
2025 Q4	$2.78M	Buy	2,600 +2,300	+767%	+$2.4M	0.19%	90
2025 Q3	$290K	Hold	300	–	–	0.02%	193
2025 Q2	$240K	Buy	+300	New	+$215K	0.02%	204
2025 Q1	–	Sell	-300	Closed	-$208K	–	217
2024 Q4	$208K	Hold	300	–	–	0.01%	215
2024 Q3	$213K	Hold	300	–	–	0.01%	225
2024 Q2	$307K	Sell	300 -2,300	-88%	-$2.21M	0.02%	211
2024 Q1	$2.52M	Hold	2,600	–	–	0.14%	111
2023 Q4	$1.97M	Hold	2,600	–	–	0.11%	117
2023 Q3	$1.53M	Hold	2,600	–	–	0.09%	129
2023 Q2	$1.88M	Buy	2,600 +700	+37%	+$476K	0.1%	126
2023 Q1	$1.29M	Hold	1,900	–	–	0.08%	143
2022 Q4	$1.04M	Hold	1,900	–	–	0.06%	159
2022 Q3	$789K	Hold	1,900	–	–	0.05%	156
2022 Q2	$904K	Buy	+1,900	New	+$1.06M	0.06%	142

Other funds holding ASML

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Cullinan Associates's ASML Position: Q1 2026 in Review

Cullinan Associates held its ASML (ASML) position steady in Q1 2026 at 2,600 shares worth $3.43M. The position accounts for 0.28% of the portfolio, ranked #72.

Cullinan Associates first reported a position in ASML in Q2 2022 and has held it in 15 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

Cullinan Associates held 2,600 shares of ASML worth $3.43M as of Q1 2026.
Cullinan Associates left its ASML share count unchanged in Q1 2026.
ASML made up 0.28% of Cullinan Associates's portfolio in Q1 2026, its #72 holding.
Cullinan Associates first reported a position in ASML in Q2 2022 and has held it in 15 quarters since.
2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.